image credit: Adobe Stock

CDC Gives Full Approval to RSV Shots, Arexvy and Abrysvo, for People Over 60; Vaccines Available This Fall

June 29, 2023


Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday.

On Thursday, Dr. Rochelle Walensky, the outgoing CDC director, gave her signature to a recommendation made last week by an advisory panel of outside experts for a single dose of the vaccines made by Pfizer and GSK. The FDA sanctioned the shots last month for adults 60 and older.

The CDC added in a statement that it is advising seniors to first consult with their doctors to determine if the vaccine is right for them.